MXPA02012501A - El uso de cuerpos grasos vegetales en sistemas de administracion de vacunas. - Google Patents
El uso de cuerpos grasos vegetales en sistemas de administracion de vacunas.Info
- Publication number
- MXPA02012501A MXPA02012501A MXPA02012501A MXPA02012501A MXPA02012501A MX PA02012501 A MXPA02012501 A MX PA02012501A MX PA02012501 A MXPA02012501 A MX PA02012501A MX PA02012501 A MXPA02012501 A MX PA02012501A MX PA02012501 A MXPA02012501 A MX PA02012501A
- Authority
- MX
- Mexico
- Prior art keywords
- bodies
- delivery systems
- plant oil
- vaccine delivery
- relates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Botany (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pulmonology (AREA)
- Transplantation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
La presente invencion se relaciona con el uso de cuerpos grasos como un sistema de administracion y adyuvante de vacunas para la administracion de vacunas por vías parenteral, mucosas (oral, nasal, pulmonar) y transdérmicas. Además, la presente invencion se relaciona con métodos de provocar una respuesta inmune en un animal administrando complejos de cuerpos grasos-antígenos al mamífero. Finalmente, la presente invencion se relaciona con métodos para preparar complejos de cuerpos grasos-antígeno.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21213000P | 2000-06-16 | 2000-06-16 | |
PCT/CA2001/000872 WO2001095934A2 (en) | 2000-06-16 | 2001-06-15 | The use of plant oil-bodies in vaccine delivery systems |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA02012501A true MXPA02012501A (es) | 2003-06-06 |
Family
ID=22789675
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA02012501A MXPA02012501A (es) | 2000-06-16 | 2001-06-15 | El uso de cuerpos grasos vegetales en sistemas de administracion de vacunas. |
Country Status (10)
Country | Link |
---|---|
US (2) | US20040081654A1 (es) |
EP (1) | EP1289549B1 (es) |
JP (1) | JP2004513879A (es) |
KR (1) | KR20030009538A (es) |
AT (1) | ATE416788T1 (es) |
AU (2) | AU6721801A (es) |
CA (1) | CA2411965A1 (es) |
DE (1) | DE60136928D1 (es) |
MX (1) | MXPA02012501A (es) |
WO (1) | WO2001095934A2 (es) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110179975A (zh) * | 2019-06-15 | 2019-08-30 | 浙江大学 | 植物油疫苗佐剂及其制备方法和用途 |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040137004A1 (en) * | 2002-03-19 | 2004-07-15 | Glenn Gregory M | Patch for transcutaneous immunization |
US7601858B2 (en) * | 2004-08-17 | 2009-10-13 | Gs Cleantech Corporation | Method of processing ethanol byproducts and related subsystems |
US9108140B2 (en) | 2005-03-16 | 2015-08-18 | Gs Cleantech Corporation | Method and systems for washing ethanol production byproducts to improve oil recovery |
AU2007217109A1 (en) * | 2006-02-16 | 2007-08-30 | Gs Industrial Design, Inc. | Method of freeing the bound oil present in whole stillage and thin stillage |
WO2007101049A2 (en) * | 2006-02-22 | 2007-09-07 | Gs Industrial Design, Inc. | Method of converting a fermentation byproduct into oxygen and biomass and related systems |
CN101506378A (zh) | 2006-06-19 | 2009-08-12 | 约翰·霍普金斯大学 | 在油包水乳液中的微粒上的单分子pcr |
DK2066341T3 (en) | 2006-09-01 | 2015-10-19 | Csl Ltd | PROCEDURE FOR INITIATING OR INDUCING AN IMMUNE RESPONSE |
NZ583377A (en) | 2007-10-12 | 2013-11-29 | Csl Ltd | Method of eliciting an immune response against pandemic influenza virus |
CA2720755A1 (en) * | 2008-04-11 | 2009-10-15 | Sembiosys Genetics, Inc. | Controlled release of active agents from oleosomes |
AU2010203223B9 (en) | 2009-01-05 | 2015-10-08 | Epitogenesis Inc. | Adjuvant compositions and methods of use |
TWI377954B (en) * | 2009-11-25 | 2012-12-01 | Univ China Medical | Oil body carriers, uses in target therapy and/or detection of the same, and fusion proteins comprised therein |
US20110229537A1 (en) * | 2010-03-17 | 2011-09-22 | Arbonne International Llc | Oral supplement |
US10561720B2 (en) | 2011-06-24 | 2020-02-18 | EpitoGenesis, Inc. | Pharmaceutical compositions, comprising a combination of select carriers, vitamins, tannins and flavonoids as antigen-specific immuno-modulators |
JP6253210B1 (ja) | 2016-08-17 | 2017-12-27 | 一般財団法人日本生物科学研究所 | 豚流行性下痢の予防又は治療方法、ワクチン、及びワクチンキット |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990002484A1 (en) * | 1988-09-06 | 1990-03-22 | Washington University | Oral immunization by transgenic plants |
US5650554A (en) * | 1991-02-22 | 1997-07-22 | Sembiosys Genetics Inc. | Oil-body proteins as carriers of high-value peptides in plants |
US5948682A (en) * | 1991-02-22 | 1999-09-07 | Sembiosys Genetics Inc. | Preparation of heterologous proteins on oil bodies |
US6034298A (en) * | 1991-08-26 | 2000-03-07 | Prodigene, Inc. | Vaccines expressed in plants |
US5612487A (en) * | 1991-08-26 | 1997-03-18 | Edible Vaccines, Inc. | Anti-viral vaccines expressed in plants |
US5484719A (en) * | 1991-08-26 | 1996-01-16 | Edible Vaccines, Inc. | Vaccines produced and administered through edible plants |
US5723755A (en) * | 1995-05-16 | 1998-03-03 | Francis E. Lefaivre | Large scale production of human or animal proteins using plant bioreactors |
US5856452A (en) * | 1996-12-16 | 1999-01-05 | Sembiosys Genetics Inc. | Oil bodies and associated proteins as affinity matrices |
WO1998053698A1 (en) * | 1997-05-27 | 1998-12-03 | Sembiosys Genetics Inc. | Uses of oil bodies |
US6761914B2 (en) * | 1997-05-27 | 2004-07-13 | Sembiosys Genetics Inc. | Immunogenic formulations comprising oil bodies |
-
2001
- 2001-06-15 MX MXPA02012501A patent/MXPA02012501A/es not_active Application Discontinuation
- 2001-06-15 KR KR1020027017186A patent/KR20030009538A/ko active IP Right Grant
- 2001-06-15 AU AU6721801A patent/AU6721801A/xx active Pending
- 2001-06-15 AU AU2001267218A patent/AU2001267218C1/en not_active Ceased
- 2001-06-15 DE DE60136928T patent/DE60136928D1/de not_active Expired - Fee Related
- 2001-06-15 JP JP2002510111A patent/JP2004513879A/ja active Pending
- 2001-06-15 US US10/297,585 patent/US20040081654A1/en not_active Abandoned
- 2001-06-15 WO PCT/CA2001/000872 patent/WO2001095934A2/en active IP Right Grant
- 2001-06-15 EP EP01944823A patent/EP1289549B1/en not_active Expired - Lifetime
- 2001-06-15 CA CA002411965A patent/CA2411965A1/en not_active Abandoned
- 2001-06-15 AT AT01944823T patent/ATE416788T1/de not_active IP Right Cessation
-
2006
- 2006-05-22 US US11/437,639 patent/US20060233816A1/en not_active Abandoned
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110179975A (zh) * | 2019-06-15 | 2019-08-30 | 浙江大学 | 植物油疫苗佐剂及其制备方法和用途 |
Also Published As
Publication number | Publication date |
---|---|
DE60136928D1 (de) | 2009-01-22 |
ATE416788T1 (de) | 2008-12-15 |
JP2004513879A (ja) | 2004-05-13 |
US20060233816A1 (en) | 2006-10-19 |
US20040081654A1 (en) | 2004-04-29 |
WO2001095934A3 (en) | 2002-08-08 |
CA2411965A1 (en) | 2001-12-20 |
WO2001095934A2 (en) | 2001-12-20 |
AU2001267218C1 (en) | 2006-07-27 |
EP1289549B1 (en) | 2008-12-10 |
AU2001267218B2 (en) | 2006-02-02 |
EP1289549A2 (en) | 2003-03-12 |
KR20030009538A (ko) | 2003-01-29 |
AU6721801A (en) | 2001-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6721801A (en) | The use of plant oil-bodies in vaccine delivery systems | |
NO20015073D0 (no) | Vaksiner | |
MY126588A (en) | Intranasal influenza virus vaccine | |
DK1404363T3 (da) | Adjuvanssammensætning til mucosalt og injektionsfremførte vacciner | |
WO2009060281A3 (en) | Immune stimulatory oligoribonucleotide analogs containing modified oligophosphate moieties | |
GB0025577D0 (en) | Vaccine | |
DK1361890T3 (da) | Influenzavaccineformuleringer til intradermal indgift | |
WO2006085983A3 (en) | Viral adjuvants | |
MX2022009167A (es) | Formulaciones para vacuna contra coronavirus. | |
AR035586A1 (es) | Composicion de vacuna, equipo, metodos para incrementar la respuesta inmune, uso de un derivado de 1h-imidazo(4,5-c)quinolin-4-amina en la fabricacion de un medicamento, y combinacion de componentes para la administracion separada, secuencial o concomitante para el uso en la vacunacion de adn | |
WO2002028422A3 (en) | Split enveloped virus preparation for intranasal delivery | |
HUP0101619A2 (hu) | Adjuvánskészítmények | |
RU2005127200A (ru) | Менингококковые вакцины для введения через слизистую оболочку | |
WO2007022151A3 (en) | Immunization of avians by administration of non-replicating vectored vaccines | |
MXPA04001509A (es) | Particulas de fosfato de calcio como coadyuvantes para la mucosa. | |
WO2006004390A3 (es) | Proceso para la preparación y uso de una vacuna bivalente contra la adicción a la morfina-heroína | |
WO2002087494A3 (en) | Novel vaccine | |
CY1112575T1 (el) | Βελτιωμενα αδρανοποιημενα εμβολια fcv | |
DE60331412D1 (de) | Hiv-vakzine und anwendungsverfahren | |
AU2003212170A8 (en) | Chemotherapeutic agents as anti-cancer vaccine adjuvants and therapeutic methods thereof | |
MY127452A (en) | Vaccines. | |
JP2004523222A5 (es) | ||
WO2002030458A8 (en) | Yersinia adhesion protein as vaccine adjuvant | |
EP1987840B1 (en) | Prime-boost vaccine for the protection of equines against viral infection | |
WO2002026254A3 (en) | Non-replicative particulate vaccine delivery system and methods of making and using same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |